
Alto Neuroscience
Clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Market cap
$112m
Enterprise value
($9m)
Share price
$3.81 ANRO
Authorizing premium user...
Clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.